Keyphrases
Diffuse Intrinsic Pontine Glioma
100%
Oncolytic Virotherapy
100%
Mesenchymal Stem Cells
100%
Oncolytic Virus
81%
Xenograft
18%
Radiotherapy
18%
Glioma Cells
18%
Brainstem
18%
Virus Entry
18%
Survivin
18%
CRAd
18%
Treatment Efficacy
9%
Tumor
9%
Surface Proteins
9%
Brain Tumor
9%
Patient Samples
9%
Survival Benefit
9%
Lysine Residue
9%
Therapeutic Strategies
9%
Irradiation
9%
Virus Replication
9%
Prolonged Survival
9%
Treatment Standards
9%
Viral Entry
9%
Glioma Therapy
9%
Glioma Tumor
9%
Study Support
9%
Patient Cells
9%
Pediatric Brain Tumor
9%
Anticancer Treatment
9%
Fiber Modification
9%
Survivin Promoter
9%
Conditional Replication
9%
Virus Delivery
9%
Medicine and Dentistry
Mesenchymal Stem Cell
100%
Pontine Glioma
100%
Oncolytic Virotherapy
100%
Oncolytic Virus
81%
Virus Entry
27%
Survivin
27%
Neoplasm
18%
Xenograft
18%
Brainstem
18%
Glioma Cell
18%
Radiation Therapy
18%
Promoter Region
9%
Combination Therapy
9%
Intracranial Tumor
9%
Low Drug Dose
9%
Cell Surface Protein
9%
Pediatric Brain Tumor
9%
Virus Replication
9%
Relative Survival
9%
Cell Line
9%
Lysine
9%
Neuroscience
Mesenchymal Stem Cell
100%
Survivin
100%
Brainstem
66%
Radiation Therapy
66%
Cell Line
33%
Lysine
33%
Pediatric Brain Tumor
33%
Promoter Region
33%
Cell Surface Protein
33%
Intracranial Tumor
33%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Virus Entry
100%
Survivin
100%
Cell Surface Protein
33%
Anticancer
33%
Promoter Region
33%
Virus Replication
33%
Low Drug Dose
33%
Lysine
33%
Immunology and Microbiology
Oncolytic Virus
100%
Mesenchymal Stem Cell
100%
Virotherapy
100%
Viral Entry
33%
Xenograft
22%
Glioma Cell
22%
Brain Stem
22%
Viral Replication
11%
Cell Line
11%
Cell Surface
11%
Promoter Region
11%
Low Drug Dose
11%
Lysine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pontine Glioma
100%
Virotherapy
100%
Oncolytic Virus
81%
Survivin
27%
Intracranial Tumor
18%
Neoplasm
18%
Cell Surface Protein
9%
Combination Therapy
9%
Lysine
9%